Literature DB >> 22987484

Reduced connexin43 expression correlates with c-Src activation, proliferation, and glucose uptake in reactive astrocytes after an excitotoxic insult.

Ester Gangoso1, Pascal Ezan, José Carlos Valle-Casuso, Sandra Herrero-González, Annette Koulakoff, Jose M Medina, Christian Giaume, Arantxa Tabernero.   

Abstract

In diverse brain pathologies, astrocytes become reactive and undergo profound phenotypic changes. Connexin43 (Cx43), the main gap junction channel-forming protein in astrocytes, is one of the proteins modified in reactive astrocytes. Downregulation of Cx43 in cultured astrocytes activates c-Src, promotes proliferation, and increases the rate of glucose uptake; however, so far there have been no studies examining whether this cascade of events takes place in reactive astrocytes. In this work, we analyzed this pathway after a cortical lesion induced by a kainic acid injection. As previously described, astrocytes reacted to the lesion with an increase in glial fibrillary acidic protein and a decrease in Cx43 expression. Some of these reactive astrocytes proliferated, as estimated by bromodeoxyuridine incorporation and cyclins D1 and D3 upregulation. In addition, the expression of the glucose transporter GLUT-3 and the enzyme responsible for glucose phosphorylation, Type II hexokinase (Hx-2), were induced in reactive astrocytes, suggesting an increased glucose uptake. Previous in vitro studies reported that c-Src is the link between Cx43 and glucose uptake and proliferation in astrocytes. Here, we found that c-Src activity increased in the lesioned area. c-Src activation and Cx43 downregulation preceded the peak of Hx-2 and cyclin D3 expression, suggesting that c-Src could mediate the effect of Cx43 on glucose uptake and proliferation in reactive astrocytes after an excitotoxic insult. Interestingly, we identify c-Src, GLUT-3, and Hx-2 in the signaling mechanisms involved in the reaction of astroglia to injury. Altogether these data contribute to identify new therapeutical targets to enhance astrocyte neuroprotective activities.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987484     DOI: 10.1002/glia.22418

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

Review 1.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

2.  Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice.

Authors:  Jonathon McClain; Vladimir Grubišić; David Fried; Roberto A Gomez-Suarez; Gina M Leinninger; Jean Sévigny; Vladimir Parpura; Brian D Gulbransen
Journal:  Gastroenterology       Date:  2013-11-06       Impact factor: 22.682

3.  Are Synchronized Changes in Connexin-43 and Caveolin-3 a Bystander Effect in a Phoneutria nigriventer Venom Model of Blood-Brain Barrier Breakdown?

Authors:  Edilene Siqueira Soares; Monique Culturato Padilha Mendonça; Thalita Rocha; Evanguedes Kalapothakis; Maria Alice da Cruz-Höfling
Journal:  J Mol Neurosci       Date:  2016-04-11       Impact factor: 3.444

4.  The SHH/Gli pathway is reactivated in reactive glia and drives proliferation in response to neurodegeneration-induced lesions.

Authors:  Kenneth L Pitter; Ilaria Tamagno; Xi Feng; Kaushik Ghosal; Nduka Amankulor; Eric C Holland; Dolores Hambardzumyan
Journal:  Glia       Date:  2014-06-04       Impact factor: 7.452

Review 5.  Targeting different domains of gap junction protein to control malignant glioma.

Authors:  Jun Wang; Ze-Yu Yang; Yu-Feng Guo; Jing-Ya Kuang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

6.  Connexin43 is required for the maintenance of multipotency in skin-derived stem cells.

Authors:  Paul W Dyce; Dan Li; Kevin J Barr; Gerald M Kidder
Journal:  Stem Cells Dev       Date:  2014-05-15       Impact factor: 3.272

7.  A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury.

Authors:  Kun Gao; Yuan Chi; Xiling Zhang; Hui Zhang; Gang Li; Wei Sun; Masayuki Takeda; Jian Yao
Journal:  J Cell Mol Med       Date:  2015-07-08       Impact factor: 5.310

8.  Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue.

Authors:  Odrick R Rosas; Aranza I Torrado; Jose M Santiago; Ana E Rodriguez; Iris K Salgado; Jorge D Miranda
Journal:  Neural Regen Res       Date:  2014-12-15       Impact factor: 5.135

Review 9.  Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target.

Authors:  Yutaka Koyama
Journal:  Front Cell Neurosci       Date:  2015-07-06       Impact factor: 5.505

10.  Triggering of protection mechanism against Phoneutria nigriventer spider venom in the brain.

Authors:  Catarina Rapôso; Paulo Alexandre Miranda Odorissi; Stefania Fioravanti Savioli; Rafaela Chitarra Rodrigues Hell; Gustavo Ferreira Simões; Roberta R Ruela-de-Sousa; Alexandre Leite Rodrigues de Oliveira; Maria Alice da Cruz-Höfling
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.